InvestorsHub Logo
Followers 1
Posts 75
Boards Moderated 0
Alias Born 05/04/2013

Re: Goldstrike post# 33026

Wednesday, 09/12/2018 12:09:56 PM

Wednesday, September 12, 2018 12:09:56 PM

Post# of 118398
“Correction: Regen BioPharma previously disclosed, in error, that "inhibiting NR2F6 is believed to provide potential therapies for treating autoimmunity." The statement should read: Activating NR2F6 potentially leads to inhibiting the immune system and should lead to therapies for treating autoimmunity diseases such as lupus.”

NR2F6 is NOT Mega Science or even science. In the world of science, this would be nothing more than a “HYPOTHESIS”!!!!!

NR2F6 is a mega-hypothesis!

RGBP stock price is down, NOT UP: .25-.15-.10-.05-.04-.03!